AU1373099A - Th2 cell depletion; compositions; methods - Google Patents

Th2 cell depletion; compositions; methods

Info

Publication number
AU1373099A
AU1373099A AU13730/99A AU1373099A AU1373099A AU 1373099 A AU1373099 A AU 1373099A AU 13730/99 A AU13730/99 A AU 13730/99A AU 1373099 A AU1373099 A AU 1373099A AU 1373099 A AU1373099 A AU 1373099A
Authority
AU
Australia
Prior art keywords
compositions
methods
cell depletion
depletion
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13730/99A
Inventor
Joseph A. Hetrick
Hortensia Soto-Trejo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU1373099A publication Critical patent/AU1373099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU13730/99A 1997-11-13 1998-11-12 Th2 cell depletion; compositions; methods Abandoned AU1373099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6539297P 1997-11-13 1997-11-13
US60065392 1997-11-13
PCT/US1998/023240 WO1999025734A2 (en) 1997-11-13 1998-11-12 Th2 CELL DEPLETION; COMPOSITIONS; METHODS

Publications (1)

Publication Number Publication Date
AU1373099A true AU1373099A (en) 1999-06-07

Family

ID=22062409

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13730/99A Abandoned AU1373099A (en) 1997-11-13 1998-11-12 Th2 cell depletion; compositions; methods

Country Status (7)

Country Link
EP (1) EP1030865A2 (en)
JP (1) JP2001523446A (en)
AR (1) AR016681A1 (en)
AU (1) AU1373099A (en)
CA (1) CA2309761A1 (en)
WO (1) WO1999025734A2 (en)
ZA (1) ZA9810371B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416954B1 (en) * 1999-02-08 2002-07-09 Schering Corporation Modulating Th2 cell levels via vMIP-I/CCR8 interaction
US6762341B2 (en) 2000-02-10 2004-07-13 Schering Corporation Uses of mammalian CCR8 receptors and related reagents
WO2001058484A2 (en) * 2000-02-10 2001-08-16 Schering Corporation Novel uses of mammalian ccr8 receptors and related reagents
AU2003229753A1 (en) * 2002-05-13 2003-11-11 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
WO2007044756A2 (en) * 2005-10-11 2007-04-19 Icos Corporation Monoclonal antibodies recognizing human ccr8
WO2014082993A2 (en) * 2012-11-30 2014-06-05 Galapagos Nv Molecular targets and compounds, and methods to identify the same, useful in the down-regulation of the th2 response
AU2017266686B2 (en) * 2016-05-16 2023-03-09 Checkmab S.R.L Markers selectively deregulated in tumor-infiltrating regulatory T cells
TW202039575A (en) * 2018-12-27 2020-11-01 日商鹽野義製藥股份有限公司 Novel anti-ccr8 antibody
CN115087488A (en) 2020-02-14 2022-09-20 震动疗法股份有限公司 Antibodies and fusion proteins binding to CCR8 and uses thereof
WO2023219147A1 (en) * 2022-05-13 2023-11-16 塩野義製薬株式会社 Novel anti-ccr8 antibodies for detecting ccr8

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364932A (en) * 1979-09-18 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same
PT843557E (en) * 1995-07-21 2003-03-31 Applied Research Systems METHODS FOR DETECTING ISOLAR INDENTIFYING AND LABELING AND SELECTING TH1 LYMPOCHOCYTES BY INTERMEDIATE LAG-3 PROTEIN
WO1997046677A1 (en) * 1996-06-05 1997-12-11 Bml, Inc. PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO

Also Published As

Publication number Publication date
AR016681A1 (en) 2001-07-25
CA2309761A1 (en) 1999-05-27
WO1999025734A3 (en) 1999-07-15
JP2001523446A (en) 2001-11-27
EP1030865A2 (en) 2000-08-30
ZA9810371B (en) 1999-08-30
WO1999025734A2 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
AUPO585797A0 (en) Improved electrochemical cell
AU5998598A (en) Electrochemical cell
AU5420699A (en) Compositions suitable for electrochemical cells
AU3826999A (en) Compositions suitable for electrochemical cells
AU9294198A (en) Cell combination to utilize available switch bandwidth
SG63814A1 (en) Thin type cell
AU1805597A (en) Electrochemical cell
AU5335798A (en) Stomatic composition
AU4040499A (en) Electrochemical cell
AU8747498A (en) Food-preservative composition
AU7562898A (en) Photovoltaic cell
AU5575398A (en) Hairdye compositions
AU1373099A (en) Th2 cell depletion; compositions; methods
AU5416998A (en) Preparation for the enhancement of the antioxidant status of cells
AU1531695A (en) Electro-chemical cell
AU8121998A (en) Composition
AU9732098A (en) Hematopoietic stem cells
KR20010012684A (en) Solar battery
AU2346800A (en) Compositions and methods using cell fusion
AU6099399A (en) Power cell
AU4942499A (en) Load cell
AU699057B2 (en) Chemical composition
AU1098499A (en) Emulsifier-lipid composition
AU6634298A (en) Biosensor for cells
AU6736598A (en) Methods for selecting cells and their uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase